Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
16.12
+0.47 (3.00%)
At close: Jan 16, 2026, 4:00 PM EST
16.24
+0.12 (0.72%)
After-hours: Jan 16, 2026, 7:47 PM EST
Omada Health Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$24.80
Upside
+53.85%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Initiates $17 | Hold | Initiates | $17 | +5.46% | Jan 9, 2026 |
| Barclays | Barclays | Buy Maintains $29 → $22 | Buy | Maintains | $29 → $22 | +36.48% | Jan 5, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $27 | Buy | Initiates | $27 | +67.49% | Nov 13, 2025 |
| Barclays | Barclays | Buy Maintains $28 → $29 | Buy | Maintains | $28 → $29 | +79.90% | Nov 7, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $27 → $28 | Buy | Maintains | $27 → $28 | +73.70% | Nov 7, 2025 |
| Needham | Needham | Strong Buy Maintains $26 → $28 | Strong Buy | Maintains | $26 → $28 | +73.70% | Nov 7, 2025 |
| Barclays | Barclays | Buy Maintains $24 → $28 | Buy | Maintains | $24 → $28 | +73.70% | Oct 22, 2025 |
| Baird | Baird | Hold Initiates $24 | Hold | Initiates | $24 | +48.88% | Sep 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $27 → $28 | Strong Buy | Maintains | $27 → $28 | +73.70% | Aug 8, 2025 |
| Barclays | Barclays | Buy Maintains $21 → $24 | Buy | Maintains | $21 → $24 | +48.88% | Aug 8, 2025 |
| Needham | Needham | Strong Buy Maintains $23 → $24 | Strong Buy | Maintains | $23 → $24 | +48.88% | Aug 8, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $20 | Buy | Initiates | $20 | +24.07% | Jul 1, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +55.09% | Jul 1, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +79.90% | Jul 1, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +67.49% | Jul 1, 2025 |
| Barclays | Barclays | Buy Initiates $21 | Buy | Initiates | $21 | +30.27% | Jul 1, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.